Back to School: How biopharma can reboot drug development. Access exclusive analysis here

LCP-Tacro tacrolimus: Phase II started

LCP began an open-label, U.S. Phase II trial in up to

Read the full 116 word article

Trial Subscription

Get a two-week free trial subscription to BioCentury

SIGN UP

Article Purchase

This article may not be distributed to non-subscribers
More Info >PURCHASE